# TAVR for Aortic Valve Disease

> **NCT05439863** · — · RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 5000 (estimated)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **DEVICE:** transcatheter heart valve

## Key facts

- **NCT ID:** NCT05439863
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2032-12-30
- **Final completion:** 2037-12-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439863, "TAVR for Aortic Valve Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05439863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*